• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观察性研究:手术切除小型无功能性胰腺神经内分泌肿瘤:基于 SEER 的研究。

Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.

机构信息

Department of General Surgery, Fujian Medical University Union Hospital, #29 Xinquan Road, Fuzhou, 350001, People's Republic of China.

出版信息

Sci Rep. 2023 Aug 7;13(1):12824. doi: 10.1038/s41598-023-39980-z.

DOI:10.1038/s41598-023-39980-z
PMID:37550460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10406806/
Abstract

The potential benefits of surgical resection for small non-functional pancreatic neuroendocrine tumors (NF-PNETs) in terms of survival remain uncertain. This study aimed to evaluate the impact of surgical treatment on patients with NF-PNETs. Using SEER data, we identified 1102 patients from 2004 to 2015 with well and moderately differentiated pancreatic neuroendocrine tumors (PNETs). The associations between continuous variables and receipt of surgery were assessed using Wilcoxon rank-sum tests. Kaplan-Meier survival curves for OS were compared using the log-rank test. We compared outcomes in patients who received surgical resection with those in patients who did not, using a univariable Cox model with inverse probability weighting according to the propensity score and propensity-score matching. Among the cohort of 1102 patients, a majority of 965 individuals (87%) underwent surgical intervention. Upon conducting univariate analysis, we observed that surgical treatment significantly prolonged patients' survival [HR = 0.41, 95% CI [0.26-0.65] P < 0.001]. However, the old [HR = 3.27, 95% CI (2.24-4.76), P 0.001], male gender [HR = 1.82, 95% CI (1.23-2.68), P = 0.003], and moderately well-differentiated factors [HR = 1.71, 95% CI (1.04-2.80), P = 0.034] were found to potentially decrease patients' survival time. In the multivariate analysis, male gender [HR = 1.73, 95% CI (1.15-2.61), P = 0.009] and the old factor [HR = 3.52, 95% CI (2.33-5.31), P < 0.001] emerged as influential predictors with higher hazard ratios. Notably, surgical treatment remained a significant factor associated with improved overall survival [HR = 0.53, 95% CI (0.33-0.84), P = 0.007]. Propensity-score matching and inverse probability weighting were employed as analytical techniques. The univariate analysis results showed favorable outcomes in the weight group [HR = 0.48, 95% CI (0.29-0.78), P = 0.003] and matched group [HR = 0.44, 95% CI (0.22-0.85), P = 0.015], respectively. Survival analysis further confirmed that surgical treatment contributed to increased overall survival (log rank, P < 0.05) in both the matching and weight groups. Patients diagnosed with small, non-functioning pancreatic neuroendocrine tumors who undergo surgical intervention exhibit improved overall survival (OS) outcomes. Therefore, surgery is strongly recommended for this patient population.

摘要

对于体积较小且无功能性的胰腺神经内分泌肿瘤(NF-PNETs),手术切除在生存方面的潜在获益仍不确定。本研究旨在评估手术治疗对 NF-PNETs 患者的影响。我们使用 SEER 数据,从 2004 年至 2015 年确定了 1102 名分化良好或中度分化的胰腺神经内分泌肿瘤(PNETs)患者。使用 Wilcoxon 秩和检验评估连续变量与手术之间的相关性。使用对数秩检验比较 OS 的 Kaplan-Meier 生存曲线。我们使用单变量 Cox 模型,根据倾向评分进行逆概率加权,并进行倾向评分匹配,比较接受手术切除和未接受手术切除的患者的结果。在 1102 例患者队列中,965 例(87%)患者接受了手术干预。进行单因素分析后,我们发现手术治疗显著延长了患者的生存时间[HR=0.41,95%CI(0.26-0.65),P<0.001]。然而,年龄较大[HR=3.27,95%CI(2.24-4.76),P<0.001]、男性[HR=1.82,95%CI(1.23-2.68),P=0.003]和中度分化[HR=1.71,95%CI(1.04-2.80),P=0.034]是降低患者生存时间的潜在因素。在多变量分析中,男性[HR=1.73,95%CI(1.15-2.61),P=0.009]和年龄较大[HR=3.52,95%CI(2.33-5.31),P<0.001]是更高风险比的影响因素。值得注意的是,手术治疗仍然是与总体生存改善相关的显著因素[HR=0.53,95%CI(0.33-0.84),P=0.007]。我们使用倾向评分匹配和逆概率加权作为分析技术。单因素分析结果显示,在权重组[HR=0.48,95%CI(0.29-0.78),P=0.003]和匹配组[HR=0.44,95%CI(0.22-0.85),P=0.015]中,结果均具有优势。生存分析进一步证实,手术治疗在匹配组和权重组中均有助于提高总体生存率(对数秩,P<0.05)。诊断为体积较小且无功能性的胰腺神经内分泌肿瘤的患者,如果接受手术干预,其总体生存率(OS)将会得到改善。因此,强烈建议对该患者群体进行手术治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d4f/10406806/53890edee017/41598_2023_39980_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d4f/10406806/f69b3f3dc7a1/41598_2023_39980_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d4f/10406806/53890edee017/41598_2023_39980_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d4f/10406806/f69b3f3dc7a1/41598_2023_39980_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d4f/10406806/53890edee017/41598_2023_39980_Fig2_HTML.jpg

相似文献

1
Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.观察性研究:手术切除小型无功能性胰腺神经内分泌肿瘤:基于 SEER 的研究。
Sci Rep. 2023 Aug 7;13(1):12824. doi: 10.1038/s41598-023-39980-z.
2
Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.手术切除原发肿瘤与低级别胰腺神经内分泌肿瘤患者的生存延长相关。
Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101432. doi: 10.1016/j.clinre.2020.04.003. Epub 2020 May 5.
3
Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study.小型无功能性胰腺神经内分泌肿瘤的预后因素和淋巴结转移风险:一项基于人群的研究。
Front Endocrinol (Lausanne). 2022 Jul 6;13:907415. doi: 10.3389/fendo.2022.907415. eCollection 2022.
4
Preoperative acute pancreatitis and hyperenzymemia are associated with poor prognosis in patients with nonfunctional pancreatic neuroendocrine tumors.术前急性胰腺炎和高酶血症与无功能性胰腺神经内分泌肿瘤患者的预后不良相关。
J Surg Oncol. 2023 Jun;127(7):1135-1142. doi: 10.1002/jso.27227. Epub 2023 Mar 13.
5
Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.分析胰腺神经内分泌肿瘤 2cm 或以下的人群水平。
Ann Surg Oncol. 2013 Sep;20(9):2815-21. doi: 10.1245/s10434-013-3005-7. Epub 2013 Jun 15.
6
Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.非转移性胰腺神经内分泌肿瘤淋巴结清扫术的结果:国家癌症数据库的倾向评分加权分析。
Ann Surg Oncol. 2019 Sep;26(9):2722-2729. doi: 10.1245/s10434-019-07506-5. Epub 2019 Jun 17.
7
A Survival Analysis of Patients with Localized, Asymptomatic Pancreatic Neuroendocrine Tumors: No Surgical Survival Benefit when Examining Appropriately Selected Outcomes.局限性无症状胰腺神经内分泌肿瘤患者的生存分析:选择合适的结局指标进行检查时,手术并不能带来生存获益。
J Gastrointest Surg. 2020 Dec;24(12):2773-2779. doi: 10.1007/s11605-019-04433-4. Epub 2019 Nov 21.
8
Prognostic significance of systemic immune-inflammation index in patients with nonfunction pancreatic neuroendocrine tumor undergoing surgical resection.系统免疫炎症指数对接受手术切除的无功能性胰腺神经内分泌肿瘤患者的预后意义。
Cancer Med. 2024 Apr;13(7):e7114. doi: 10.1002/cam4.7114.
9
Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.高分化无功能性胰腺神经内分泌肿瘤切除术后复发情况分析
Medicine (Baltimore). 2020 Jun 12;99(24):e20324. doi: 10.1097/MD.0000000000020324.
10
Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.局部进展期胰腺神经内分泌肿瘤手术治疗效果评价。
JAMA Netw Open. 2020 Nov 2;3(11):e2024318. doi: 10.1001/jamanetworkopen.2020.24318.

引用本文的文献

1
Surgical Versus Nonsurgical Management of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.胰腺神经内分泌肿瘤的手术治疗与非手术治疗:一项系统评价与Meta分析
Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17819-3.
2
Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-Up.手术切除的高分化胰腺神经内分泌肿瘤的预后特征:对904例患者进行7882人年随访的分析
Endocr Pathol. 2025 Jun 27;36(1):24. doi: 10.1007/s12022-025-09866-z.
3
Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-Up.

本文引用的文献

1
[The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020)].[中国胰腺神经内分泌肿瘤诊断和治疗指南(2020年版)]
Zhonghua Wai Ke Za Zhi. 2021 Jun 1;59(6):401-421. doi: 10.3760/cma.j.cn112139-20210319-00135.
2
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.NCCN 指南解读:神经内分泌和肾上腺肿瘤,第 2.2018 版。
J Natl Compr Canc Netw. 2018 Jun;16(6):693-702. doi: 10.6004/jnccn.2018.0056.
3
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
手术切除的高分化胰腺神经内分泌肿瘤的预后特征:对904例患者进行7882人年随访的分析
medRxiv. 2025 Apr 3:2025.04.01.25325055. doi: 10.1101/2025.04.01.25325055.
美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
4
Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection.胰腺神经内分泌肿瘤(panNETs):非手术治疗与手术切除的总生存期分析
J Gastrointest Surg. 2017 May;21(5):855-866. doi: 10.1007/s11605-017-3365-6. Epub 2017 Mar 2.
5
A practical guide to propensity score analysis for applied clinical research.实用倾向评分分析指南:应用于临床研究
Behav Res Ther. 2017 Nov;98:76-90. doi: 10.1016/j.brat.2017.01.005. Epub 2017 Jan 19.
6
Inverse probability weighting.逆概率加权法。
BMJ. 2016 Jan 15;352:i189. doi: 10.1136/bmj.i189.
7
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.小的无症状胰腺神经内分泌肿瘤的观察与切除:一项配对病例对照研究
Ann Surg Oncol. 2016 Apr;23(4):1361-70. doi: 10.1245/s10434-015-4986-1. Epub 2015 Nov 23.
8
Neuroendocrine tumors, version 1.2015.神经内分泌肿瘤,第 1.2015 版。
J Natl Compr Canc Netw. 2015 Jan;13(1):78-108. doi: 10.6004/jnccn.2015.0011.
9
Practical management and treatment of pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤的实际管理与治疗
Gland Surg. 2014 Nov;3(4):276-83. doi: 10.3978/j.issn.2227-684X.2013.12.05.
10
Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors.手术切除为小胰腺神经内分泌肿瘤患者带来总生存获益。
J Gastrointest Surg. 2015 Jan;19(1):117-23; discussion 123. doi: 10.1007/s11605-014-2615-0. Epub 2014 Aug 26.